AHF urges Gilead to create initial price on newest HIV/AIDS drug combination AIDS Healthcare Foundation announced that California State Treasurer Bill Lockyer has sent a letter to California-based drug business, Gilead Sciences, Inc online . Unreasonable drug prices are putting an unbearable strain on taxpayer-funded, cash-strapped State AIDS Drug Assistance Programs in California and around the national country, ultimately limiting usage of lifesaving HIV/AIDS treatment to those most in want. ADAPs means AIDS Drug Assistance Applications, a nationwide network of federal government and state funded aid programs offering lifesaving HIV/AIDS medicines to low-income individuals.
GlobalPost notes that it co-produced a segment examining the U.S. HIV/Helps epidemic with PBS NewsHour that aired on Thursday . This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an editorially independent news service, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.. AIDS 2012 could focus spotlight on attempts against HIV/AIDS in U.S., GlobalPost reports Noting that Washington, D.C., has an adult HIV prevalence rate higher than some southern African countries that receive PEPFAR funding, GlobalPost writes that the International Helps Conference, to be kept in the U.S.